![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Exclusive | Behind the billionaire-backed longevity business — and …
Jan 7, 2025 · Tech billionaires like Jeff Bezos, Sam Altman and Peter Thiel are pouring massive amounts of their fortune into the longevity industry. Here's what innovations are in the pipeline.
Sam Altman invested $180 million into a company trying to delay …
Mar 8, 2023 · When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million to bankroll an audacious mission: to add 10 years to …
OpenAI has created an AI model for longevity science
Jan 17, 2025 · Sam Altman, the CEO of OpenAI, personally funded Retro with $180 million, as MIT Technology Review first reported in 2023. Retro has the goal of extending the normal …
OpenAI's Sam Altman invested in bioscience aging startup
Mar 8, 2023 · At startup incubator Y Combinator, Sam Altman got interested in aging research after an experiment with old and young mice, MIT Tech Review reported.
Jeff Bezos, Mark Zuckerberg And Sam Altman Among The …
Oct 2, 2023 · OpenAI CEO Sam Altman invested $180 million in Retro Biosciences, a company looking for ways to rejuvenate the body's T cells, which are crucial for fighting cancer and …
Inside Sam Altman’s Anti-Aging Routine, Diet, and Sleep Habits
May 24, 2023 · Sam Altman wants to reverse aging. From taking Metformin to investing in anti-aging research, everything he’s doing to optimize his lifespan.
OpenAI CEO Sam Altman Takes Diabetes Drug Metformin to Slow Aging …
Mar 8, 2023 · OpenAI CEO Sam Altman takes the diabetes drug metformin to slow down aging. His anti-aging regimen also includes healthy eating, exercising, and getting enough sleep. …
Sam Altman's Retro Biosciences Aims for Longer Lifespans by 10 …
Mar 23, 2024 · Sam Altman started a $180 million side project called Retro Biosciences, hoping to add 10 healthy, enjoyable years onto the back end of our lifespans.
OpenAI CEO invested $180 million in longevity company Retro Bio
Mar 9, 2023 · OpenAI CEO Sam Altman revealed as mystery investor behind longevity biotech that aims to increase healthy human lifespan by 10 years.
Behind the billionaire-backed longevity business — and the
Jan 7, 2025 · OpenAI CEO Sam Altman (left), Amazon’s Jeff Bezos (center), and PayPal cofounder Peter Thiel (right) have all funded longevity startups. New York Post graphic. But …